vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and Triumph Financial, Inc. (TFIN). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $120.1M, roughly 1.6× Triumph Financial, Inc.). On growth, Triumph Financial, Inc. posted the faster year-over-year revenue change (16.0% vs 11.1%). Over the past eight quarters, Triumph Financial, Inc.'s revenue compounded faster (9.0% CAGR vs 6.5%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

The Triumph Motor Company was a British car and motor manufacturing company in the 19th and 20th centuries. The marque had its origins in 1885 when Siegfried Bettmann of Nuremberg formed S. Bettmann & Co. and started importing bicycles from Europe and selling them under his own trade name in London. The trade name became "Triumph" the following year, and in 1887 Bettmann was joined by a partner, Moritz Schulte, also from Germany. In 1889, the businessmen started producing their own bicycles i...

NEO vs TFIN — Head-to-Head

Bigger by revenue
NEO
NEO
1.6× larger
NEO
$186.7M
$120.1M
TFIN
Growing faster (revenue YoY)
TFIN
TFIN
+4.9% gap
TFIN
16.0%
11.1%
NEO
Faster 2-yr revenue CAGR
TFIN
TFIN
Annualised
TFIN
9.0%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NEO
NEO
TFIN
TFIN
Revenue
$186.7M
$120.1M
Net Profit
$-108.0M
Gross Margin
43.3%
Operating Margin
46.9%
Net Margin
-57.9%
Revenue YoY
11.1%
16.0%
Net Profit YoY
42.0%
400.6%
EPS (diluted)
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
TFIN
TFIN
Q1 26
$186.7M
Q4 25
$190.2M
$120.1M
Q3 25
$187.8M
$109.3M
Q2 25
$181.3M
$108.1M
Q1 25
$168.0M
$101.6M
Q4 24
$172.0M
$103.6M
Q3 24
$167.8M
$106.2M
Q2 24
$164.5M
$105.1M
Net Profit
NEO
NEO
TFIN
TFIN
Q1 26
$-108.0M
Q4 25
Q3 25
$-27.1M
$1.7M
Q2 25
$-45.1M
$4.4M
Q1 25
$-25.9M
$17.0K
Q4 24
$3.8M
Q3 24
$-17.7M
$5.3M
Q2 24
$-18.6M
$2.7M
Gross Margin
NEO
NEO
TFIN
TFIN
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
NEO
NEO
TFIN
TFIN
Q1 26
46.9%
Q4 25
-7.1%
Q3 25
-14.4%
1.2%
Q2 25
-26.3%
7.3%
Q1 25
-16.6%
0.1%
Q4 24
-10.7%
5.6%
Q3 24
-12.6%
5.9%
Q2 24
-13.3%
3.4%
Net Margin
NEO
NEO
TFIN
TFIN
Q1 26
-57.9%
Q4 25
Q3 25
-14.4%
1.6%
Q2 25
-24.9%
4.1%
Q1 25
-15.4%
0.0%
Q4 24
3.7%
Q3 24
-10.5%
5.0%
Q2 24
-11.3%
2.6%
EPS (diluted)
NEO
NEO
TFIN
TFIN
Q1 26
$-0.13
Q4 25
Q3 25
$0.04
Q2 25
$0.15
Q1 25
$-0.03
Q4 24
$0.13
Q3 24
$0.19
Q2 24
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
TFIN
TFIN
Cash + ST InvestmentsLiquidity on hand
$146.1M
$248.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.8M
$941.8M
Total Assets
$1.3B
$6.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
TFIN
TFIN
Q1 26
$146.1M
Q4 25
$159.6M
$248.5M
Q3 25
$164.1M
$147.2M
Q2 25
$154.7M
$282.3M
Q1 25
$346.2M
$502.9M
Q4 24
$367.0M
$330.1M
Q3 24
$362.0M
$489.3M
Q2 24
$355.1M
$500.7M
Total Debt
NEO
NEO
TFIN
TFIN
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
NEO
NEO
TFIN
TFIN
Q1 26
$828.8M
Q4 25
$836.6M
$941.8M
Q3 25
$838.3M
$919.3M
Q2 25
$854.0M
$912.4M
Q1 25
$888.3M
$893.9M
Q4 24
$902.3M
$890.9M
Q3 24
$908.2M
$885.8M
Q2 24
$915.9M
$874.2M
Total Assets
NEO
NEO
TFIN
TFIN
Q1 26
$1.3B
Q4 25
$1.4B
$6.4B
Q3 25
$1.4B
$6.4B
Q2 25
$1.4B
$6.5B
Q1 25
$1.6B
$6.3B
Q4 24
$1.6B
$5.9B
Q3 24
$1.6B
$5.9B
Q2 24
$1.6B
$5.8B
Debt / Equity
NEO
NEO
TFIN
TFIN
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
TFIN
TFIN
Operating Cash FlowLast quarter
$-8.1M
$67.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
TFIN
TFIN
Q1 26
$-8.1M
Q4 25
$1.3M
$67.1M
Q3 25
$8.9M
$24.4M
Q2 25
$20.3M
$9.8M
Q1 25
$-25.3M
$-3.6M
Q4 24
$9.8M
$58.5M
Q3 24
$9.2M
$26.6M
Q2 24
$13.9M
$21.9M
Free Cash Flow
NEO
NEO
TFIN
TFIN
Q1 26
Q4 25
$-6.5M
Q3 25
$570.0K
$22.4M
Q2 25
$14.0M
$6.8M
Q1 25
$-29.8M
$-7.9M
Q4 24
$-1.8M
Q3 24
$-1.6M
$25.8M
Q2 24
$814.0K
$-31.9M
FCF Margin
NEO
NEO
TFIN
TFIN
Q1 26
Q4 25
-3.4%
Q3 25
0.3%
20.5%
Q2 25
7.7%
6.2%
Q1 25
-17.8%
-7.7%
Q4 24
-1.0%
Q3 24
-0.9%
24.3%
Q2 24
0.5%
-30.3%
Capex Intensity
NEO
NEO
TFIN
TFIN
Q1 26
Q4 25
4.1%
Q3 25
4.4%
1.8%
Q2 25
3.5%
2.8%
Q1 25
2.7%
4.2%
Q4 24
6.7%
Q3 24
6.4%
0.8%
Q2 24
8.0%
51.1%
Cash Conversion
NEO
NEO
TFIN
TFIN
Q1 26
Q4 25
Q3 25
14.29×
Q2 25
2.22×
Q1 25
-212.82×
Q4 24
15.25×
Q3 24
4.97×
Q2 24
7.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons